CONFIDENCE Visual Abstract

Check out the beautiful visual abstract made by NephJC intern Michelle Fravel.

View fullsize

Ensayo STAMP: ¿Tacrolimus o Micofenolato en el síndrome nefrótico pediátrico?

El síndrome nefrótico en niños puede implicar recaídas frecuentes, alta carga de esteroides y decisiones terapéuticas difíciles. Entonces, ¿cuál mantiene mejor la remisión: tacrolimus o micofenolato de mofetilo?

Revisa el VA y únete a la discusión en #NephJC

The STAMP Trial VA: Who Gets the Approval—TAC or MMF in Pediatric Nephrotic Syndrome?

Nephrotic syndrome in kids can mean frequent relapses, high steroid burden, and tough treatment choices. So which helps maintain remission better: Tacrolimus or MMF?

See the Visual Abstract Krithika Mohan

TAC or MMF—what works better in pediatric nephrotic syndrome?

Nephrotic syndrome in children, especially those with frequent relapses or steroid dependence, remains a therapeutic challenge. The STAMP trial compared tacrolimus and mycophenolate mofetil to help guide treatment decisions.

Does desmopressin help with post kidney biopsy bleeding?

Check out this thread, summarizing discussions on two studies.

Does Lorundrostat Effectively Lower Blood Pressure in Uncontrolled Hypertension?

Stunning visual abstract summarizing NEJM study, by Priti Meena

Does your heart skip a beat with chronic hyperkalemia in dialysis?

ADAPT trial: fixing the K+ numbers, while hoping to translate them into outcomes

Is a lower BP the road to better outcomes in diabetes?

How low is too low for blood pressure? Will BPROAD get to the bottom of this issue?

Pain Coping Skills Training in Diaysis

Can we train to deal with the pain? HOPE trial shows us that non-pharmacological intervention can be an option. Visual abstract by Cristina Popa

View fullsize